Additionally, SAMC can reduce inflammatory responses by targeting NF-κB, and improve lipid homeostasis and insulin resistance through regulating AMPK and IRS-1/PI3K/Akt pathways (Xiao et al., 2013a). The gene discussed is NFKB1; the disease is Insulin resistance.